Schizophrenia Read time: 7 min Satellite symposiumArticle Long-acting antipsychotic treatment: Initiation and optimisation In an Industry sponsored symposium titled “Optimising long-acting therapy use in... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Satellite symposiumArticle New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention... Content action menuShareTestTest 2Test 3
Schizophrenia Read time: 4 min Satellite symposiumArticle Why patients with schizophrenia do not socially engage? Dr Michael F. Green (Geffen School of Medicine, UCLA; VA Rehabilitation R&D Center on Enhancing... Content action menuShareTestTest 2Test 3
Parkinson's Disease Read time: 3 min Congress highlightsArticle Exercise and dopaminergic therapy for early Parkinson’s disease What type of exercise should patients diagnosed with early Parkinson’s disease do to improve... Content action menuShareTestTest 2Test 3
Depression, Schizophrenia Read time: 3 min Satellite symposiumArticle Act early to improve outcomes in schizophrenia and major depressive disorder At the 35th ECNP Congress in Vienna, Austria (15th−18th Oct), in a symposium... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Satellite symposiumArticle Patient-centric management of medication-overuse headache Medication overuse is common among patients who are impacted by migraine and up to 70% of patients... Content action menuShareTestTest 2Test 3